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Background
Evidence has been provided linking neurogenesis to
mood disorders. Notably, it has been shown that chronic
experimental stress resulting in enhanced depression-like
behavior decreases neurogenesis in the dentate gyrus
(DG), while antidepressants reverse these stress-induced
effects. However, in most studies ''normal'' animals
reflecting physiology rather than pathophysiology are
used. Therefore, we aimed to investigate neurogenesis in
the DG of a mouse model of high-trait anxiety and comor-
bid depression (HAB), which mimics important features
of human psychopathology, and their normal anxiety/
depression (NAB) controls.
Methods
BrdU (5-bromo-2'-deoxyuridine) was administered to
female HABs and NABs. Mice were sacrificed at 15 and 42
days post BrdU to study cell proliferation and survival
respectively. At 42 d the mice were subjected to a forced
swim test. Double labelling of BrdU and c-Fos (a marker
for neuronal activation) was performed to observe if new-
born cells functionally integrated into the DG network.
Furthermore, effects of the selective serotonin reuptake
inhibitor (SSRI) fluoxetine on depression-like behavior
and cell survival were assessed. Finally, gene array studies
were conducted in the DG.
Results
Compared to NABs, HAB mice displayed enhanced
depression-like behavior in the forced swim test and
reduced newborn cell proliferation and survival in the
DG. Double-labelling of BrdU and c-Fos revealed that
some of the newborn cells in the survival paradigm func-
tionally integrated in NABs, while no such evidence was
found in HABs. Gene array studies revealed lower abun-
dance of cyclin-dependent kinase 5 (Cdk5) and brain-
derived neurotrophic factor (BDNF) in HABs which might
contribute to reduced neurogenesis. Finally, although
chronic treatment with fluoxetine reduced the depression-
like behavior exclusively in female HABs, it did not alter
cell survival or functional integration of newborn neurons
in the DG.
Conclusion
Taken together, the enhanced depression-like behavior in
a psychopathological animal model is accompanied by
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decreased hippocampal neurogenesis as well as BDNF
and CdK5 expression possibly contributing to the pheno-
type. Since the antidepressant effect of fluoxetine is dis-
cerned from neurogenesis, it is suggested that
mechanisms other than adult neurogenesis underlie the
therapeutic action of SSRIs in the HAB model, which,
however, has to be confirmed by using additional SSRIs.
Thus, the present data do not support the idea that neuro-
genesis is a prerequisite for therapeutic actions common
to all antidepressants. Moreover, these findings highlight
the importance of psychopathological animal models in
order to investigate molecular mechanisms of effective
antidepressants.
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